NVCR
insider transactionsNovoCure Ltd — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-54.9K
0 buy · 54.9K sell
Net value · 30d
-$939.7K
$0 in · $939.7K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
8
0 buy · 54.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
10.9K sh
Own +76%
-
Sell·S
Frank X Leonard KEY
Chief Executive Officer
$614.6K
34.3K sh · $17.93
Own -7%
-
Grant·A
Director
$0
11.0K sh
Own +33%
-
Grant·A
Director
$0
17.0K sh
Own New
-
Grant·A
Director
$0
11.6K sh
Own +103%
-
Grant·A
Director
$0
17.0K sh
Own New
-
Grant·A
Director
$0
11.6K sh
Own +103%
-
Grant·A
Director
$0
17.0K sh
Own New
-
Grant·A
Director
$0
11.6K sh
Own +81%
-
Grant·A
Director
$0
17.0K sh
Own New
-
Grant·A
Director
$0
11.6K sh
Own +6%
-
Grant·A
Director
$0
17.0K sh
Own New
-
Grant·A
Director
$0
11.6K sh
Own +62%
-
Grant·A
Director
$0
17.0K sh
Own New
-
Grant·A
Director
$0
11.6K sh
Own +13%
-
Grant·A
Director
$0
17.0K sh
Own New
-
Grant·A
Director
$0
11.6K sh
Own +57%
-
Grant·A
Director
$0
17.0K sh
Own New
-
Grant·A
Director
$0
11.6K sh
Own +84%
-
Sell·S
Director
$46.4K
2.9K sh · $15.77
Own -21%
-
Sell·S
Director
$46.4K
2.9K sh · $15.77
Own -21%
-
Sell·S
Director
$46.4K
2.9K sh · $15.77
Own -17%
-
Sell·S
Director
$46.4K
2.9K sh · $15.77
Own -1%
-
Sell·S
Director
$46.4K
2.9K sh · $15.77
Own -3%
-
Sell·S
Director
$46.4K
2.9K sh · $15.77
Own -13%
-
Sell·S
Director
$46.4K
2.9K sh · $15.77
Own -18%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Jeryl L Hilleman | Grant A | 10.9K | $0 |
| Jun 4, 2026 | Frank X Leonard KEY | Sell S | 34.3K | $614.6K |
| Jun 4, 2026 | Jeryl L Hilleman | Grant A | 11.0K | $0 |
| Jun 3, 2026 | Kristin Stafford | Grant A | 17.0K | $0 |
| Jun 3, 2026 | Kristin Stafford | Grant A | 11.6K | $0 |
| Jun 3, 2026 | Allyson J Ocean | Grant A | 17.0K | $0 |
| Jun 3, 2026 | Allyson J Ocean | Grant A | 11.6K | $0 |
| Jun 3, 2026 | Timothy J Scannell | Grant A | 17.0K | $0 |
| Jun 3, 2026 | Timothy J Scannell | Grant A | 11.6K | $0 |
| Jun 3, 2026 | Anthony W Vernon | Grant A | 17.0K | $0 |
| Jun 3, 2026 | Anthony W Vernon | Grant A | 11.6K | $0 |
| Jun 3, 2026 | Martin J. Madden | Grant A | 17.0K | $0 |
| Jun 3, 2026 | Martin J. Madden | Grant A | 11.6K | $0 |
| Jun 3, 2026 | Gabriel Leung | Grant A | 17.0K | $0 |
| Jun 3, 2026 | Gabriel Leung | Grant A | 11.6K | $0 |
| Jun 3, 2026 | David Hung | Grant A | 17.0K | $0 |
| Jun 3, 2026 | David Hung | Grant A | 11.6K | $0 |
| Jun 3, 2026 | Jeryl L Hilleman | Grant A | 17.0K | $0 |
| Jun 3, 2026 | Jeryl L Hilleman | Grant A | 11.6K | $0 |
| Jun 2, 2026 | Kristin Stafford | Sell S | 2.9K | $46.4K |
| Jun 2, 2026 | Allyson J Ocean | Sell S | 2.9K | $46.4K |
| Jun 2, 2026 | Timothy J Scannell | Sell S | 2.9K | $46.4K |
| Jun 2, 2026 | Anthony W Vernon | Sell S | 2.9K | $46.4K |
| Jun 2, 2026 | Gabriel Leung | Sell S | 2.9K | $46.4K |
| Jun 2, 2026 | David Hung | Sell S | 2.9K | $46.4K |
| Jun 2, 2026 | Jeryl L Hilleman | Sell S | 2.9K | $46.4K |
About NVCR insider trading
This page tracks insider transactions for NovoCure Ltd (NVCR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.